Researcher.Life Logo

Microbial Drug Resistance : Impact Factor & More

eISSN: 1931-8448pISSN: 1076-6294

Key Metrics

CiteScore
5.7
H-Index
75
Impact Factor
< 5
SJR
Q2Immunology
SNIP
0.93
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Microbial Drug Resistance

Microbial Drug Resistance Journal Specifications

Overview
Publisher MARY ANN LIEBERT, INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1995
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Microbial Drug Resistance ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Microbial Drug Resistance

Association of katG, inhA, and AhpC Mutations with Isoniazid Resistance of Mycobacterium tuberculosis in Pulmonary Tuberculosis Patients from Nanjing, China.
  • 27 Apr 2026
  • Microbial drug resistance (Larchmont, N.Y.)
Antimicrobial Resistance Patterns and Microbial Epidemiology of Oral and Maxillofacial Space Infections: A Systematic Review and Meta-Analysis.
  • 21 Apr 2026
  • Microbial drug resistance (Larchmont, N.Y.)
Rapid but Transient Microevolution with Minimal Recombination During High-Transmission Streptococcus pneumoniae Carriage in a Day-Care Cohort.
  • 2 Apr 2026
  • Microbial drug resistance (Larchmont, N.Y.)
Show Me the "Mino:" In Vitro Efficacy of Minocycline on Clinical Gram-Negative Bacterial Isolates.
  • 1 Apr 2026
  • Microbial drug resistance (Larchmont, N.Y.)
Pyelonephritis Caused by Pseudomonas aeruginosa: From Treatable Infection to Therapeutic Dead-End, Rescued by an Investigational Antibiotic.
  • 1 Apr 2026
  • Microbial drug resistance (Larchmont, N.Y.)
Evolution of the Burden of Carbapenem-Resistant Klebsiella pneumoniae Infections in the Elderly, 1990-2021: Global Trends, Regional Heterogeneity, and Health Inequalities.
  • 1 Apr 2026
  • Microbial drug resistance (Larchmont, N.Y.)
Association of katG, inhA, and AhpC Mutations with Isoniazid Resistance of Mycobacterium tuberculosis in Pulmonary Tuberculosis Patients from Nanjing, China.
  • 27 Apr 2026
  • Microbial drug resistance (Larchmont, N.Y.)
Antimicrobial Resistance Patterns and Microbial Epidemiology of Oral and Maxillofacial Space Infections: A Systematic Review and Meta-Analysis.
  • 21 Apr 2026
  • Microbial drug resistance (Larchmont, N.Y.)
Rapid but Transient Microevolution with Minimal Recombination During High-Transmission Streptococcus pneumoniae Carriage in a Day-Care Cohort.
  • 2 Apr 2026
  • Microbial drug resistance (Larchmont, N.Y.)
Show Me the "Mino:" In Vitro Efficacy of Minocycline on Clinical Gram-Negative Bacterial Isolates.
  • 1 Apr 2026
  • Microbial drug resistance (Larchmont, N.Y.)
Pyelonephritis Caused by Pseudomonas aeruginosa: From Treatable Infection to Therapeutic Dead-End, Rescued by an Investigational Antibiotic.
  • 1 Apr 2026
  • Microbial drug resistance (Larchmont, N.Y.)
Evolution of the Burden of Carbapenem-Resistant Klebsiella pneumoniae Infections in the Elderly, 1990-2021: Global Trends, Regional Heterogeneity, and Health Inequalities.
  • 1 Apr 2026
  • Microbial drug resistance (Larchmont, N.Y.)

FAQs on Microbial Drug Resistance